BRAF/MEK inhibition in NSCLC: Mechanisms of resistance and how to overcome it
I Tsamis, G Gomatou, SP Chachali, IP Trontzas… - Clinical and …, 2023 - Springer
… to RAF and MEK inhibitor therapy [57]. Combined YAP and RAF or MEK inhibition was …
a biomarker of worse initial response to RAF and MEK inhibition in patients, indicating the …
a biomarker of worse initial response to RAF and MEK inhibition in patients, indicating the …
Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer
… inhibitor inhibited the proliferation of LGSOC cells In light of the early promising data on the
use of MEK inhibitors in … to confirm the effects of combining these drugs with metformin in a …
use of MEK inhibitors in … to confirm the effects of combining these drugs with metformin in a …
[HTML][HTML] Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
MW Chao, LH Chang, HJ Tu, CD Chang, MJ Lai… - Clinical …, 2019 - Springer
… of the Ras-Raf-MEK-ERK pathway. Administration of a MEK inhibitor alone failed to provide
… Therefore, we combined an HDAC inhibitor with a MEK inhibitor, which had a synergistic …
… Therefore, we combined an HDAC inhibitor with a MEK inhibitor, which had a synergistic …
BRAF and MEK inhibition in melanoma
LA Dossett, RR Kudchadkar… - Expert opinion on drug …, 2015 - Taylor & Francis
… New evidence suggests that the combination of BRAF and MEK inhibitors … ) and MEK (trametinib)
inhibitors as well as the available data on BRAF inhibitor + MEK inhibitor combination …
inhibitors as well as the available data on BRAF inhibitor + MEK inhibitor combination …
… of the MEK1(F129L) Activating Mutation as a Potential Mechanism of Acquired Resistance to MEK Inhibition in Human Cancers Carrying the B-RafV600E Mutation
H Wang, S Daouti, W Li, Y Wen, C Rizzo, B Higgins… - Cancer research, 2011 - AACR
… Together, our results indicate that the combination of Raf and MEK inhibition could be a
potential therapeutic strategy not only to enhance clinical efficacy but also to bypass or prevent …
potential therapeutic strategy not only to enhance clinical efficacy but also to bypass or prevent …
Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK …
JG Greger, SD Eastman, V Zhang, MR Bleam… - Molecular cancer …, 2012 - AACR
… resistance and the RAF–MEK–ERK pathway contributes to mTOR activity, … combination
of BRAF or MEK inhibitors with a PI3K/mTOR inhibitor may overcome acquired BRAF inhibitor …
of BRAF or MEK inhibitors with a PI3K/mTOR inhibitor may overcome acquired BRAF inhibitor …
MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells
… following kinase inhibition. MoDC cross-… combined inhibition of MEK and BRAF. The results
of this study demonstrate that MEK inhibition, alone or in combination with BRAF inhibition, …
of this study demonstrate that MEK inhibition, alone or in combination with BRAF inhibition, …
[HTML][HTML] Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials
R Mai, S Zhou, W Zhong, S Rong, Z Cong, Y Li, Q Xie… - Oncotarget, 2015 - ncbi.nlm.nih.gov
… the effectiveness of combined BRAF and MEK inhibition with PFS, ORR, and OS. Currently,
the network meta-analysis supports the combined BRAF and MEK inhibition is the preferred …
the network meta-analysis supports the combined BRAF and MEK inhibition is the preferred …
[HTML][HTML] Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3
EV Abel, KJ Basile, CH Kugel… - The Journal of …, 2013 - Am Soc Clin Investig
… received either RAF inhibitor or combined RAF/MEK inhibitor. The latter combination has …
survival in mutant BRAF melanoma patients compared with RAF inhibitor alone (37). Three out …
survival in mutant BRAF melanoma patients compared with RAF inhibitor alone (37). Three out …
[HTML][HTML] Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
A Del Curatolo, F Conciatori, U Cesta Incani… - Journal of Experimental …, 2018 - Springer
… As assessed by IP/WB, both RAF inhibitors caused … RAF and MEK inhibition in BRAF-wt/RAS-Mut
contexts We then analyzed the functional effects of combined BRAF and MEK inhibition …
contexts We then analyzed the functional effects of combined BRAF and MEK inhibition …